These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Exophthalmos in a young woman with no graves' disease - a case report of IgG4-related orbitopathy. Erdei A; Steiber Z; Molnar C; Berenyi E; Nagy EV BMC Ophthalmol; 2018 Jan; 18(1):5. PubMed ID: 29329570 [TBL] [Abstract][Full Text] [Related]
4. [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer]. Bałdys-Waligórska A; Gołkowski F; Sokołowski G; Buziak-Bereza M; Skalski M; Hubalewska-Dydejczyk A Endokrynol Pol; 2008; 59(6):516-20. PubMed ID: 19347817 [TBL] [Abstract][Full Text] [Related]
5. Reactivation of Graves' orbitopathy after rehabilitative orbital decompression. Baldeschi L; Lupetti A; Vu P; Wakelkamp IM; Prummel MF; Wiersinga WM Ophthalmology; 2007 Jul; 114(7):1395-402. PubMed ID: 17320178 [TBL] [Abstract][Full Text] [Related]
6. Effect of orbital decompression on diplopia in thyroid-related orbitopathy. Mainville NP; Jordan DR Ophthalmic Plast Reconstr Surg; 2014; 30(2):137-40. PubMed ID: 24481502 [TBL] [Abstract][Full Text] [Related]
9. Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease. Hwang CJ; Rebollo NP; Mechels KB; Perry JD Am J Ophthalmol; 2024 Jul; 263():152-159. PubMed ID: 38142982 [TBL] [Abstract][Full Text] [Related]
10. The initial clinical characteristics of Graves' orbitopathy vary with age and sex. Kendler DL; Lippa J; Rootman J Arch Ophthalmol; 1993 Feb; 111(2):197-201. PubMed ID: 8431156 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic medial orbital fat decompression for proptosis in type 1 graves orbitopathy. Wu W; Selva D; Bian Y; Wang X; Sun MT; Kong Q; Yan W Am J Ophthalmol; 2015 Feb; 159(2):277-84. PubMed ID: 25448997 [TBL] [Abstract][Full Text] [Related]
13. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy. Laurberg P; Berman DC; Andersen S; Bülow Pedersen I Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677 [TBL] [Abstract][Full Text] [Related]
14. Radiotherapy in the management of thyroid orbitopathy. Computed tomography and clinical outcomes. Kao SC; Kendler DL; Nugent RA; Adler JS; Rootman J Arch Ophthalmol; 1993 Jun; 111(6):819-23. PubMed ID: 8512483 [TBL] [Abstract][Full Text] [Related]
15. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
17. Orbital decompression for thyroid orbitopathy. McNab AA Aust N Z J Ophthalmol; 1997 Feb; 25(1):55-61. PubMed ID: 9107397 [TBL] [Abstract][Full Text] [Related]
18. Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome. Ben Simon GJ; Wang L; McCann JD; Goldberg RA Thyroid; 2004 May; 14(5):379-83. PubMed ID: 15186616 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy. Kim JW; Han SH; Son BJ; Rim TH; Keum KC; Yoon JS Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240 [TBL] [Abstract][Full Text] [Related]